Why Rockwell Medical, Inc.’s (RMTI) Stock Is Down 6.16%

By Cynthia McLaughlin
August 22, 2026
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Rockwell Medical, Inc. before investing.

In this article, we go over a few key elements for understanding Rockwell Medical, Inc.’s stock price such as:

  • Rockwell Medical, Inc.’s current stock price and volume
  • Why Rockwell Medical, Inc.’s stock price changed recently
  • Upgrades and downgrades for RMTI from analysts
  • RMTI’s stock price momentum as measured by its relative strength

About Rockwell Medical, Inc. (RMTI)

Before we jump into Rockwell Medical, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company’s hemodialysis concentrate products are used to sustain patient’s life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Want to learn more about Rockwell Medical, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Rockwell Medical, Inc..

Learn More About A+ Investor

Rockwell Medical, Inc.’s Stock Price as of Market Close

As of August 21, 2026, 4:00 PM, CST, Rockwell Medical, Inc.’s stock price was $8.100.

Rockwell Medical, Inc. is up 6.02% from its previous closing price of $7.640.

During the last market session, Rockwell Medical, Inc.’s stock traded between $7.555 and $8.100. Currently, there are approximately 3.96 million shares outstanding for Rockwell Medical, Inc..

Rockwell Medical, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Rockwell Medical, Inc. Stock Price History

Rockwell Medical, Inc.’s (RMTI) price is currently up 12.66% so far this month.

During the month of August, Rockwell Medical, Inc.’s stock price has reached a high of $8.100 and a low of $6.600.

Over the last year, Rockwell Medical, Inc. has hit prices as high as $21.000 and as low as $4.885. Year to date, Rockwell Medical, Inc.’s stock is down 2.82%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Rockwell Medical, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of August 21, 2026, there were analysts who downgraded Rockwell Medical, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Rockwell Medical, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Rockwell Medical, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Rockwell Medical, Inc.’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Rockwell Medical, Inc. (RMTI) by visiting AAII Stock Evaluator.

Relative Price Strength of Rockwell Medical, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of August 21, 2026, Rockwell Medical, Inc. has a weighted four-quarter relative price strength of -9.37%, which translates to a Momentum Score of 22 and is considered to be Weak.

Want to learn more about how Rockwell Medical, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Rockwell Medical, Inc. Stock Price: Bottom Line

As of August 21, 2026, Rockwell Medical, Inc.’s stock price is $8.100, which is up 6.02% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Rockwell Medical, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
High Relative Dividend
Yield Screen:
8.7% Compared to S&P 500
at only 6.9%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.